alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Administrative Office of the United States Courts FOR COURT USE ONLY

TRANSCRIPT ORDER

DUE DATE:

OAO 435

AZ Form (Rev. 1/2015)

1. NAME 2. PHONE NUMBER 3. DATE

4. FIRM NAME

5. MAILING ADDRESS 6. CITY 7. STATE 8. ZIP CODE

9. CASE NUMBER 10. JUDGE DATES OF PROCEEDINGS

11. 12. 

13. CASE NAME LOCATION OF PROCEEDINGS

14. 15. STATE

16. ORDER FOR

9 APPEAL 9 CRIMINAL

9 NON-APPEAL 9 CIVIL

9 CRIMINAL JUSTICE ACT

9 

IN FORMA PAUPERIS

BANKRUPTCY

OTHER (Specify)

17. TRANSCRIPT REQUESTED (Specify portion(s) and date(s) of proceeding(s) for which transcript is requested.)

PORTIONS DATE(S) PORTION(S) DATE(S)

9TESTIMONY (Specify)

9PRE-TRIAL PROCEEDING

9OTHER (Specify)

9VOIR DIRE

9OPENING STATEMENT (Plaintiff)

9OPENING STATEMENT (Defendant)

9CLOSING ARGUMENT (Plaintiff)

9CLOSING ARGUMENT (Defendant)

9OPINION OF COURT

9JURY INSTRUCTIONS

9SENTENCING

9BAIL HEARING

18. ORDER

CATEGORY

ORIGINAL + 1

(original to Court,

copy to ordering party)

FIRST

COPY

# OF

ADDITIONAL

COPIES

DELIVERY INSTRUCTIONS

(Check all that apply.)

ESTIMATED COSTS

30 DAYS 9 9 PAPER COPY

PDF (e-mail)

ASCII (e-mail)

14 DAYS 9 9

7 DAYS 9 9

DAILY 9 9

HOURLY 9 9

REALTIME 9 9

CERTIFICATION (19. & 20.)

By signing below, I certify that I will pay all charges

(deposit plus additional).

E-MAIL ADDRESS

NOTE: IF ORDERING MORE THAN ONE FORMAT, 

THERE WILL BE AN ADDITIONAL CHARGE.

19. SIGNATURE

20. DATE

TRANSCRIPT TO BE PREPARED BY

ESTIMATE TOTAL

PROCESSED BY PHONE NUMBER

ORDER RECEIVED DATE BY

DEPOSIT PAID DEPOSIT PAID

TRANSCRIPT ORDERED TOTAL CHARGES

TRANSCRIPT RECEIVED LESS DEPOSIT

ORDERING PARTY NOTIFIED

TO PICK UP TRANSCRIPT

TOTAL REFUNDED

PARTY RECEIVED TRANSCRIPT TOTAL DUE

DISTRIBUTION: COURT COPY TRANSCRIPTION COPY ORDER RECEIPT ORDER COPY

Case 2:15-md-02641-DGC Document 8863 Filed 11/20/17 Page 1 of 1
{"version":"1.0","provider_name":"NASA","provider_url":"https:\/\/www.nasa.gov","author_name":"Alivia R. Carruth","author_url":"https:\/\/www.nasa.gov\/author\/arcarrut\/","title":"STS-51I","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FC1odVVz3g\"><a href=\"https:\/\/www.nasa.gov\/gallery\/sts-51i\/\">STS-51I<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.nasa.gov\/gallery\/sts-51i\/embed\/#?secret=FC1odVVz3g\" width=\"600\" height=\"338\" title=\"“STS-51I” — NASA\" data-secret=\"FC1odVVz3g\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n"}
##### 



1.
    
    the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended
June 30, 2006 (the Report), filed with the U.S. Securities and Exchange Commission, fully
complies with the requirements of Section 13(a) or 15(d) of the Securities and Exchange Act of
1934, as amended; and2.
    
    the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 Date: August 7, 2006
    
    
    
    /s/ ANTONIO B. MON

Antonio B. MonChief Executive Officer
Return
      to Main Document





EXHIBIT
      32.1








CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION906
      OF THE SARBANES-OXLEY ACT OF 2002








In
      connection with the Quarterly Report of Mexoro Minerals Limited (the “Company”)
      on Form 10-QSB/A for the quarter ended November 30, 2006, as filed with
      the
      United States Securities and Exchange Commission on the date hereof (the
      “Report”), the undersigned, in the capacities and on the dates indicated below,
      hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
      Section 906 of the Sarbanes-Oxley Act of 2002, that to his
      knowledge:








(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the
      Securities Exchange Act of 1934; as amended; and








(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.














Date:
      March 16, 2007


/s/
      Robert Knight


Chief
      Executive Officer
#### STATE OF NEW JERSEY v. ARNETT THOMAS.

July 11, 1989.

Petition for certification denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE STUDENT
LOAN CORPORATION QUARTERLY REPORT ON FORM 10-Q FOR THE THREE MONTH PERIOD ENDED
JUNE 30,1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             214
<SECURITIES>                                         0
<RECEIVABLES>                                9,108,253
<ALLOWANCES>                                     2,405
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               9,404,850
<CURRENT-LIABILITIES>                                0
<BONDS>                                      4,569,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           200
<OTHER-SE>                                     495,249
<TOTAL-LIABILITY-AND-EQUITY>                 9,404,850
<SALES>                                        172,646
<TOTAL-REVENUES>                               173,291
<CGS>                                                0
<TOTAL-COSTS>                                  115,041
<OTHER-EXPENSES>                                18,192
<LOSS-PROVISION>                                 1,261
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                 38,797
<INCOME-TAX>                                    16,157
<INCOME-CONTINUING>                             22,640
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    22,640
<EPS-BASIC>                                     1.13
<EPS-DILUTED>                                     1.13


</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 9
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-2000
<PERIOD-START>                             JUL-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                             940
<INT-BEARING-DEPOSITS>                           1,060
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                        469
<INVESTMENTS-CARRYING>                           4,018
<INVESTMENTS-MARKET>                             3,885
<LOANS>                                         69,129
<ALLOWANCE>                                        434
<TOTAL-ASSETS>                                  77,039
<DEPOSITS>                                      41,530
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                                152
<LONG-TERM>                                      7,900
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            22
<OTHER-SE>                                      27,435
<TOTAL-LIABILITIES-AND-EQUITY>                  77,039
<INTEREST-LOAN>                                  2,506
<INTEREST-INVEST>                                  159
<INTEREST-OTHER>                                    36
<INTEREST-TOTAL>                                 2,701
<INTEREST-DEPOSIT>                               1,006
<INTEREST-EXPENSE>                               1,136
<INTEREST-INCOME-NET>                            1,565
<LOAN-LOSSES>                                        0
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                    770
<INCOME-PRETAX>                                    849
<INCOME-PRE-EXTRAORDINARY>                           0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       532
<EPS-BASIC>                                       0.30
<EPS-DILUTED>                                     0.30
<YIELD-ACTUAL>                                    4.33
<LOANS-NON>                                        208
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                    266
<ALLOWANCE-OPEN>                                   444
<CHARGE-OFFS>                                       10
<RECOVERIES>                                         0
<ALLOWANCE-CLOSE>                                  434
<ALLOWANCE-DOMESTIC>                               323
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                            111


</TABLE>
II 

108TH CONGRESS 

2D SESSION S. 2667 

To amend section 641 of the Medicare Prescription Drug, Improvement, 

and Modernization Act of 2003 to improve the coverage of certain prescription drugs and biologicals under the medicare replacement drug 

demonstration project. 

IN THE SENATE OF THE UNITED STATES 

JULY 15, 2004 

Mr. DAYTON introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To amend section 641 of the Medicare Prescription Drug, 

Improvement, and Modernization Act of 2003 to improve 

the coverage of certain prescription drugs and biologicals 

under the medicare replacement drug demonstration 

project. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Medicare Replacement 

5 Drug Demonstration Project Improvement Act of 2004’’. 
2 

•S 2667 IS 

1 SEC. 2. MEDICARE REPLACEMENT DRUG DEMONSTRATION 

2 PROJECT IMPROVEMENT. 

3 (a) REQUIREMENT TO NEGOTIATE REDUCED DRUG

4 PRICES.—Section 641(a) of the Medicare Prescription 

5 Drug, Improvement, and Modernization Act of 2003 (42 

6 U.S.C. 1395l note) is amended by inserting after the first 

7 sentence the following new sentence: ‘‘Notwithstanding 

8 any other provision of law, the Secretary shall negotiate 

9 the lowest possible price for the drugs and biologicals for 

10 which payment is made under the demonstration project.’’. 

11 (b) ELIMINATION OF LIMITATIONS; FUNDING.—Sec12 tion 641(d) of the Medicare Prescription Drug, Improve13 ment, and Modernization Act of 2003 (42 U.S.C. 1395l 

14 note) is amended to read as follows: 

15 ‘‘(d) FUNDING.—There are appropriated from the 

16 Federal Supplementary Medical Insurance Trust Fund 

17 under section 1841 of the Social Security Act (42 U.S.C. 

18 1395t) such sums as are necessary to provide coverage 

19 for drugs and biologicals for which payment is made under 

20 the demonstration project for each individual who is eligi21 ble to participate in such demonstration project.’’. 

22 (c) EFFECTIVE DATE; EXTENSION OF APPLICATION

23 DEADLINE.— 

24 (1) EFFECTIVE DATE.—The amendments made 

25 by this section shall take effect as if included in the 

26 enactment of section 641 of the Medicare Prescrip-
3 

•S 2667 IS 

1 tion Drug, Improvement, and Modernization Act of 

2 2003 (42 U.S.C. 1395l note). 

3 (2) EXTENSION OF APPLICATION DEADLINE.— 

4 The Secretary shall extend any application deadline 

5 imposed under the demonstration project under sec6 tion 641 of the Medicare Prescription Drug, Im7 provement, and Modernization Act of 2003 (42 

8 U.S.C. 1395l note) until at least the date that is 90 

9 days after the date of enactment of this Act. 

Æ
UNITED STATES DISTRICT COURT

FOR THE 

DISTRICT OF ARIZONA

William Johnson,

Plaintiff,

v.

C. R. Bard Inc. and Bard Peripheral 

Vascular, Inc.,

Defendant.

)

)

)

)

)

)

)

)

)

MDL Case No. 2:15-md-02641-DGC

Civil Action No. CV-17-03728-PHX-DGC

WAIVER OF THE SERVICE OF SUMMONS

To: Freese & Goss PLLC - Birmingham, AL

(Name of plaintiff’s attorney or unrepresented plaintiff)

I have received your request to waive service of a summons in this action along with a copy of the complaint, two 

copies of this waiver form, and a prepaid means of returning one signed copy of the form to you.

I, or the entity I represent, agree to save the expense of serving a summons and complaint in this case.

I understand that I, or the entity I represent, will keep all defenses or objections to the lawsuit, the court’s 

jurisdiction, and the venue of the action, but that I waive any objections to the absence of a summons or of service.

I also understand that I, or the entity I represent, must file and serve an answer or a motion under Rule 12 within 

60 days from 11/14/2017, the date when this request was sent (or 90 days if it was sent outside the United States). If I fail 

to do so, a default judgment will be entered against me or the entity I represent.

Date: November 27, 2017 /s/ Richard B. North, Jr.

Signature of the attorney or unrepresented party

C. R. Bard, Inc. and Bard Peripheral

Vascular, Inc.

Printed name of parties waiving service of 

summons

Richard B. North, Jr. (Ga. Bar No. 545599)

Printed Name

Nelson Mullins Riley & Scarborough, LLP

201 17th St., NW, Suite 1700, Atlantic Station, Atlanta, GA 30363

Address

richard.north@nelsonmullins.com

E-mail Address

(404) 322-6155

Telephone number

Duty to Avoid Unnecessary Expenses of Serving a Summons

Rule 4 of the Federal Rules of Civil Procedure requires certain defendants to cooperate in saving unnecessary expenses of serving a 

summons and complaint. A defendant who is located in the United States and who fails to return a signed waiver of service requested by a plaintiff 

located in the United States will be required to pay the expenses of service, unless the defendant shows good cause for the failure. 

“Good cause” does not include a belief that the lawsuit is groundless, or that it has been brought in an improper venue, or that the court has 

no jurisdiction over this matter or over the defendant or the defendant’s property. 

If the waiver is signed and returned, you can still make these and all other defenses and objections, but you cannot object to the absence of 

a summons or of service. 

If you waive service, then you must, within the time specified on the waiver form, serve an answer or a motion under Rule 12 on the 

plaintiff and file a copy with the court. By signing and returning the waiver form, you are allowed more time to respond than if a summons had been 

served.

Case 2:15-md-02641-DGC Document 9234 Filed 12/06/17 Page 1 of 1
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           4,002
<SECURITIES>                                         0
<RECEIVABLES>                                    1,870
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                         461,952
<DEPRECIATION>                                  33,340
<TOTAL-ASSETS>                                 515,784
<CURRENT-LIABILITIES>                                0
<BONDS>                                        279,355
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            90
<OTHER-SE>                                     112,975
<TOTAL-LIABILITY-AND-EQUITY>                   515,784
<SALES>                                              0
<TOTAL-REVENUES>                                70,194
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              14,145
<INCOME-PRETAX>                                  3,178
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (4,410)
<EPS-PRIMARY>                                   (0.49)
<EPS-DILUTED>                                   (0.33)


</TABLE>
Exhibit 10.34(a)



                                                                December 2, 1999



Mr. H. E. Tad Kinne
107 Heming Way
Stamford  CT  06903


                                    Re:      1999 MICP Award

Dear Mr. Kinne:

     As you are aware,  the Executive  Compensation  Committee has awarded you a
special grant of nonqualified  stock options in lieu of a cash bonus award under
the Company's  Management  Incentive  Compensation  Plan for 1999. The Committee
recognizes  that its  decision to make your 1999 award in a form other than cash
could have the  unintended  effect of reducing  certain  payments or benefits to
which you may be entitled under the Executive Severance Agreement dated February
3, 1999 and the Executive Deferred  Compensation and Consulting  Agreement dated
July 15, 1998 between you and the Company (the  "Agreements").  As a result, the
Committee has determined that, notwithstanding anything in the Agreements to the
contrary, the calculation of any payments or benefits to you, your beneficiaries
or legal  representatives under the Agreements shall be made as though your 1999
bonus award had been paid to you in cash in the amount of $159,250.

     The Company hereby declares this undertaking to be irrevocable and made for
the benefit of you, your beneficiaries and legal representatives.


                                            Hexcel Corporation




                                            By: ________________________________



Acknowledged


--------------------------
Executive

                                      168
<PAGE>
II 

108TH CONGRESS 

2D SESSION S. 2496 

To provide for the relief of Helen L. O’Leary. 

IN THE SENATE OF THE UNITED STATES 

JUNE 3, 2004 

Mr. BAYH introduced the following bill; which was read twice and referred to 

the Committee on Armed Services 

A BILL 

To provide for the relief of Helen L. O’Leary. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. RELIEF OF HELEN L. O’LEARY. 

4 (a) IN GENERAL.—Notwithstanding section 

5 3702(e)(3) of title 31, United States Code, or any other 

6 limitation on the authority of the Secretary of Defense to 

7 settle claims for survivor benefits of members of the 

8 Armed Forces, the Secretary of Defense shall pay Helen 

9 L. O’Leary of South Bend, Indiana, the amount of 

10 $66,258, which amount represents the balance of the un11 paid survivor benefits payable to Helen L. O’Leary by rea-
2 

•S 2496 IS 

1 son of the death of her husband, Francis O’Leary, a 

2 former member of the Armed Forces, in September 1979. 

3 (b) FUNDS.—Amounts for the payment required by 

4 subsection (a) shall be derived from amounts available to 

5 the Secretary of the military department concerned for the 

6 payment of survivor benefits. 

7 (c) LIMITATION ON FEES.—Not more than a total 

8 of 10 percent of the payment required by subsection (a) 

9 may be paid to or received by agents or attorneys for serv10 ices rendered in connection with obtaining such payment, 

11 any contract to the contrary notwithstanding. Any person 

12 who violates this subsection shall be fined not more than 

13 $1,000. 

Æ
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-02-1999
<PERIOD-END>                               APR-02-1999
<CASH>                                             376
<SECURITIES>                                         0
<RECEIVABLES>                                   16,013
<ALLOWANCES>                                       860
<INVENTORY>                                     15,071
<CURRENT-ASSETS>                                35,307
<PP&E>                                          34,443
<DEPRECIATION>                                  12,827
<TOTAL-ASSETS>                                  93,102
<CURRENT-LIABILITIES>                           15,173
<BONDS>                                        140,000
<PREFERRED-MANDATORY>                           18,663
<PREFERRED>                                      3,000
<COMMON>                                        25,464
<OTHER-SE>                                   (114,774)
<TOTAL-LIABILITY-AND-EQUITY>                    93,102
<SALES>                                         28,634
<TOTAL-REVENUES>                                28,634
<CGS>                                           20,430
<TOTAL-COSTS>                                   20,430
<OTHER-EXPENSES>                                 4,973
<LOSS-PROVISION>                                    48
<INTEREST-EXPENSE>                               3,738
<INCOME-PRETAX>                                  (555)
<INCOME-TAX>                                     (221)
<INCOME-CONTINUING>                              3,183
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (334)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>